# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000320017-23-000023
Filing Date
2023-05-01
Accepted
2023-05-01 16:03:28
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | defa14anotice20230428.htm | DEFA14A | 11762
2 |  | proxynotice04202023_pagex1a.jpg | GRAPHIC | 500113
3 |  | proxynotice04202023_pagex2a.jpg | GRAPHIC | 450139
| Complete submission text file | 0000320017-23-000023.txt |  | 1321397

Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33650 | Film No.: 23873483
SIC: 8090 Services-Misc Health & Allied Services, NEC